Board Meeting18 May 2026, 02:37 pm
Lincoln Pharma Board Meeting on May 28, 2026
AI Summary
Lincoln Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 28, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board will also consider the recommendation of a dividend on equity shares, if any. The trading window has been closed from April 1, 2026, and will reopen 48 hours after the results are generally available.
Key Highlights
- Board meeting scheduled for May 28, 2026, to approve audited financial results.
- Consideration of dividend on equity shares is on the agenda.
- Trading window closed from April 1, 2026, reopening post-results announcement.
Price Impact
More from LINCOPH